Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Automating Total Tumor Volume (TTV) generation on 177Lu-PSMA SPECT/CT using deep learning to create normal organs on the CT for automatic physiological uptake removal in patients with metastatic castration resistant prostate cancer (mCRPC)

Peter Wilson, Remy Niman, Timothy Susman, Sarennya Pathmanandavel, Louise Emmett and Aaron Nelson
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P914;
Peter Wilson
1MIM Software Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remy Niman
2MIM Software, Inc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Susman
1MIM Software Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarennya Pathmanandavel
3Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
3Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Nelson
1MIM Software Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P914

Introduction: There is evidence to suggest Total Tumor Volume (TTV) and Whole Body SUVmean on quantitative 177Lu-PSMA SPECT/CT (Lu-SPECT) predicts outcomes in patients with metastatic castration resistant prostate cancer (mCRPC) receiving 177Lu-PSMA therapy (Pathmanandavel S et al. JNM 2022; John N et al. JNM 2022). Generating TTV is a time-consuming process. This study evaluated the accuracy of an algorithm to automatically generate TTV on Lu-SPECT.

Methods: 95 quantitative 24-hour post 177Lu-PSMA therapy SPECT/CT scans from 36 patients with mCRPC were used from the LuPIN Trial (Pathmanandavel S et al. JNM 2022). Patients received between 1 and 6 cycles of therapy with each cycle occurring every six weeks. The Gold Standard (GS) VOIs were segmented by a nuclear medicine physician using a 3 SUV threshold followed by manual edits. The proposed algorithm segmented all VOIs in the image with a 3 SUV threshold. Then, utilizing normal structures created by a CT-based deep learning convolutional neural network, VOIs contained within organs with physiological uptake were removed from the proposed segmentation. Organ contours used in the algorithm included: liver, kidneys, parotids, submandibular glands, lacrimal glands, bone, bowel, pelvic lymph nodes, prostate, and bladder (Buteau JP et al. JNM 2022). A paired, two-tailed t-test was used to determine statistical significance, with an α of 0.05 indicating a significant difference.

Results: The average TTV for the proposed method was 927 mL (土 988) compared to the average GS TTV of 847 mL (土 910), which was not significantly different (p=0.054). The average absolute difference in TTV between the proposed method and the GS was 110 mL (土 393). Note that with 4 outliers removed, the difference reduces to 34.3 mL (土 55.1) (p=0.46). The correlation coefficient between the proposed method TTV and the GS was 0.84. The proposed method resulted in an average of 25.5 mL (土 28.4) of uptake that was falsely included and an average of 3.42 mL (土 0.43) of uptake that was either falsely removed or not captured. The average SUVmean of the GS was 8.96 SUV (土 3.34), while the average SUVmean of the proposed method was 8.60 SUV (土 3.11). This difference in SUVmean between the proposed method and the GS was significantly different (p=0.03). Although significantly different, the average relative error in SUVmean was 4.7% (土 9.7%), and the median relative error in SUVmean was 1.4%.

Conclusions: The proposed method utilized CT-based, deep learning generated normal organs for automatic removal of physiologic uptake on Lu-SPECT. This method produced comparable TTV and Whole Body SUVmean to that produced by an expert. A small but statistically significant difference in SUVmean was identified between the proposed automated method and the GS, however the clinical significance of this is unclear, and little manual editing would likely be needed to match the GS. A tool using the proposed method could increase efficiency and reproducibility when generating TTV and Whole Body SUVmean for the assessment of 177Lu-PSMA therapy, but additional investigation is needed to assess the actual amount of time saved when utilizing this method of automatic physiological uptake removal.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Automating Total Tumor Volume (TTV) generation on 177Lu-PSMA SPECT/CT using deep learning to create normal organs on the CT for automatic physiological uptake removal in patients with metastatic castration resistant prostate cancer (mCRPC)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Automating Total Tumor Volume (TTV) generation on 177Lu-PSMA SPECT/CT using deep learning to create normal organs on the CT for automatic physiological uptake removal in patients with metastatic castration resistant prostate cancer (mCRPC)
Peter Wilson, Remy Niman, Timothy Susman, Sarennya Pathmanandavel, Louise Emmett, Aaron Nelson
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P914;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Automating Total Tumor Volume (TTV) generation on 177Lu-PSMA SPECT/CT using deep learning to create normal organs on the CT for automatic physiological uptake removal in patients with metastatic castration resistant prostate cancer (mCRPC)
Peter Wilson, Remy Niman, Timothy Susman, Sarennya Pathmanandavel, Louise Emmett, Aaron Nelson
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P914;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Spatiotemporal kinetic modeling of radiopharmaceutical therapies at cellular resolution in heterogeneous tumors
  • Using long-axial field-of-view dynamic 2-[18F]FDG PET/CT to create deep learning-based synthetic contrast enhanced CT images – assessment of the clinical acceptability of a novel method
  • Volumetric Brain Tumor Segmentation in High-Grade Glioma Using a Semi-Automated Workflow
Show more Oncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire